Continuous Glucose Monitoring Technology in the Perioperative Period During Cardiac Surgery

This study is currently recruiting participants.
Verified July 2011 by Yale University
Sponsor:
Collaborators:
Medtronic
Information provided by:
Yale University
ClinicalTrials.gov Identifier:
NCT01394588
First received: July 12, 2011
Last updated: July 13, 2011
Last verified: July 2011
  Purpose

This is an observational study of continuous glucose monitoring technology during cardiac surgery. The investigators would like to develop data for descriptive analysis of a comparison of continuous glucose monitoring with a gold standard under the conditions of cardiac surgery.


Condition Intervention
Cardiac Surgery
Device: Use of continuous glucose monitor during surgery. ( Medtronic Minimed Guardian REALTime Continuous Glucose Monitor)

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: A Prospective Observational Trial of Continuous Glucose Monitoring Technology in the Perioperative Period During Cardiac Surgery

Resource links provided by NLM:


Further study details as provided by Yale University:

Estimated Enrollment: 50
Study Start Date: August 2010
Groups/Cohorts Assigned Interventions
Cardiac Surgery Patients
Competent Adult Patients going for elective cardiac surgery.
Device: Use of continuous glucose monitor during surgery. ( Medtronic Minimed Guardian REALTime Continuous Glucose Monitor)
Use of continuous glucose monitor during surgery.
Other Name: Medtronic Minimed Guardian REALTime Continuous Glucose Monitor

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Competent adults scheduled for elective cardiac surgery.

Criteria

Inclusion Criteria:

  • Competent adults scheduled for elective cardiac surgery.

Exclusion Criteria:

  • Inability to consent, emergency surgery.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01394588

Contacts
Contact: Robert Schonberger, MD 2037852802 robert.schonberger@yale.edu

Locations
United States, Connecticut
Yale New Haven Hospital Recruiting
New Haven, Connecticut, United States, 06510
Sponsors and Collaborators
Yale University
Medtronic
Investigators
Principal Investigator: Robert Schonberger, MD Yale University
  More Information

No publications provided

Responsible Party: Robert Schonberger, Yale University
ClinicalTrials.gov Identifier: NCT01394588     History of Changes
Other Study ID Numbers: 1006006996
Study First Received: July 12, 2011
Last Updated: July 13, 2011
Health Authority: United States: Institutional Review Board

Keywords provided by Yale University:
Cardiac Surgery
Perioperative Glucose Control

ClinicalTrials.gov processed this record on May 23, 2013